Biofidelity: Funding, Investors & Team (Oct 2026)
Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences. Biofidelity’s mission is to improve and extend patients’ lives by enabling early detection of disease and better targeting of treatments with applications spanning oncology, prenatal testing, infectious disease, and organ transplant monitoring. Biofidelity was founded in 2019 and is headquartered of Cambridge, England.
Biofidelity has raised $59.0M across 3 funding rounds on record, the most recent an undisclosed round of $24.0M announced in Apr 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Biofidelity Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Biofidelity Funding Rounds
Biofidelity raised $12.0M in an undisclosed round announced in Aug 2020.
1.5 years later, a Series A of $23.0M was announced in Feb 2022.
2.2 years later, an undisclosed round of $24.0M was announced in Apr 2024.
Biofidelity Founders and Leadership Team
Contact details for the Biofidelity team: 2 of 2 have an email address on file.
Start 14-day free trial →Biofidelity Funding Compared to Other Biotechnology Startups
Biofidelity's latest round of $24.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biofidelity in Biotechnology and Cambridge
Companies Similar to Biofidelity
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Biofidelity Funding FAQs
What does Biofidelity do?
Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences. Biofidelity’s mission is to improve and extend patients’ lives by enabling early detection of disease and better targeting of treatments with applications spanning oncology, prenatal testing, infectious disease, and organ transplant monitoring. Biofidelity was founded in 2019 and is headquartered of Cambridge, England.
How much funding has Biofidelity raised?
Biofidelity has raised $59.0M across 3 rounds on record. The most recent is an undisclosed round of $24.0M announced in Apr 2024.
When did Biofidelity last raise funding?
Biofidelity's most recent funding round on record is an undisclosed round of $24.0M, announced in Apr 2024.
Who founded Biofidelity?
FundedIQ lists Barnaby Balmforth (Founder) at Biofidelity.
Who is the CEO of Biofidelity?
Barney Balmforth is listed as CEO at Biofidelity.
Where is Biofidelity headquartered?
Biofidelity is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Biofidelity have?
Biofidelity is in the 11-50 employee band.
How does Biofidelity's funding compare to other Biotechnology startups?
Biofidelity's latest round of $24.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Biofidelity Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biofidelity is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.